Cargando…
Comparative survival analysis of breast cancer microarray studies identifies important prognostic genetic pathways
BACKGROUND: An estimated 12% of females in the United States will develop breast cancer in their lifetime. Although, there are advances in treatment options including surgery and chemotherapy, breast cancer is still the second most lethal cancer in women. Thus, there is a clear need for better metho...
Autores principales: | Miecznikowski, Jeffrey C, Wang, Dan, Liu, Song, Sucheston, Lara, Gold, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972286/ https://www.ncbi.nlm.nih.gov/pubmed/20964848 http://dx.doi.org/10.1186/1471-2407-10-573 |
Ejemplares similares
-
Error control variability in pathway-based microarray analysis
por: Gold, David L., et al.
Publicado: (2009) -
A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
por: Haibe-Kains, B., et al.
Publicado: (2008) -
Genome-wide screen identifies a novel prognostic signature for breast cancer survival
por: Mao, Xuan Y, et al.
Publicado: (2017) -
Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?
por: Sucheston-Campbell, Lara E., et al.
Publicado: (2015) -
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
por: Colombo, Pierre-Emmanuel, et al.
Publicado: (2011)